Found 7 matching trials
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer PHASE2 This study is being done to answer the following question: Can testing brea...
Show More Location
Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
Study of RP-3500, Camonsertib, in Advanced Solid Tumors PHASE1 The primary purpose of this study is to define the maximum tolerated dose (...
Show More Location
#1014, Northwestern University
Learn More & Join Trial
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) PHASE1 This study will evaluate the efficacy, safety, and pharmacokinetics of immu...
Show More Location
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
Learn More & Join Trial
Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors PHASE1 The primary purpose of this study is to assess the safety and tolerability ...
Show More Location
Participating Site #1018
Learn More & Join Trial
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma PHASE1 This phase I trial tests the safety, side effects, and best dose of camonse...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study PHASE2 TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study...
Show More Status
Active Not Recruiting
Location
Western Regional Medical Center at Cancer Treatment Centers of America
Learn More & Join Trial
RP-6306 in Patients With Advanced Cancer PHASE2 This study is being done to answer the following questions:
* Is the new d...
Show More Learn More & Join Trial